Back to CM Management, LLC

CM Management, LLC

All holdings · as of Dec 31, 2025

62 positions

CompanyClassValueShares% of portfolio
RIGEL PHARMACEUTICALS, INC.$9.64M225,0008.1%
TASEKO MINES LTD$9.62M1,700,0008.1%
Alico, Inc.ALCOCommon Stock$7.28M200,0006.1%
AMICUS THERAPEUTICS INC$5.27M370,0004.4%
Preformed Line Products CoPLPCCommon Stock$5.17M25,0004.4%
Radiant Logistics, Inc.$4.11M650,0003.5%
BGC Group Inc$3.57M400,0003.0%
NEWMARK GROUP, INC.$3.29M190,0002.8%
inTEST Corp$3.12M417,5002.6%
Coherus Oncology, Inc.$2.98M2,100,0002.5%
ROYALTY PHARMA PLC SHS$2.90M75,0002.4%
CENTERRA GOLD INC$2.87M200,0002.4%
Keurig Dr Pepper Inc$2.80M100,0002.4%
Viatris Inc$2.49M200,0002.1%
MarineMax, Inc.$2.42M100,0002.0%
Park Hotels & Resorts Inc.$2.35M225,0002.0%
REPUBLIC BANCORP INC /KYRBCAACommon Stock$2.21M32,0001.9%
TALOS ENERGY INC.$2.20M200,0001.9%
Coya Therapeutics, Inc.COYACommon Stock$2.03M350,0001.7%
PagerDuty, Inc.$1.97M150,0001.7%
ARKO Corp.$1.82M400,0001.5%
FRACTYL HEALTH, INC.GUTSCommon Stock$1.76M800,0001.5%
Evolus, Inc.$1.66M250,0001.4%
Innospec Inc$1.53M20,0001.3%
ARK RESTAURANTS CORP$1.51M225,0001.3%
COGNYTE SOFTWARE LTD ORD$1.50M160,0001.3%
Crescent Energy Co$1.47M175,0001.2%
Alexandria Real Estate Equities Inc$1.47M30,0001.2%
Bristow Group Inc.$1.46M40,0001.2%
Organon & Co.$1.43M200,0001.2%
FIRST FINANCIAL CORP /IN$1.36M22,5001.1%
LyondellBasell Industries N.V.$1.30M30,0001.1%
Beacon Financial Corp$1.27M48,3001.1%
Atea Pharmaceuticals, Inc.$1.27M355,0001.1%
SCOTTS MIRACLE-GRO CO$1.17M20,0001.0%
ClearPoint Neuro, Inc.$1.09M80,0000.9%
1ST SOURCE CORP$1.09M17,5000.9%
IOVANCE BIOTHERAPEUTICS, INC.$1.09M400,0000.9%
Sabre Corp$1.09M800,0000.9%
XOMA Royalty Corp$1.06M40,0000.9%
AMCON DISTRG CO$997.2K9,0000.8%
Eledon Pharmaceuticals, Inc.$981.5K650,0000.8%
HERON THERAPEUTICS, INC. /DE$975.0K750,0000.8%
Euronet Worldwide Inc$951.4K12,5000.8%
COLUMBUS MCKINNON CORP$948.8K55,0000.8%
Cytosorbents CorpCTSOCommon Stock$943.8K1,476,5000.8%
NEWELL BRANDS INC.$744.0K200,0000.6%
Service Properties Trust$736.0K400,0000.6%
Lantern Pharma Inc.$681.8K225,0000.6%
PROFOUND MED CORP$629.6K80,0000.5%
← PrevPage 1 of 2Next →